Second, while CCL4 inhibition could improve the phosphorylation of IRS-1 in skeletal muscle and liver tissues in type 2 DM and metabolic syndrome model mice, further experiments are needed to explore the role of CCL4-related inflammation in the development of insulin resistance, such as inflammation in adipose tissues. This evidence concerns the gene IRS1 and metabolic syndrome.